您的位置: 首页 > 农业专利 > 详情页

isoxazole derivative as mutant isocitrate dehydrogenase 1 inhibitor
专利权人:
DAIICHI SANKYO COMPANY, LIMITED;NATIONAL CANCER CENTER
发明人:
HIDEAKI WATANABE,HIRONAO SAITO,HIRONORI MATSUNAGA,KAZUHIRO KAGOSHIMA,KAZUO KITABAYASHI,MASAO ITOH,SHOICHI SAITO,TETSUNORI FUJISAWA,TETSUYA SUZUKI,YOHEI KIYOTSUKA,YOKO OGAWARA
申请号:
BR112017006425
公开号:
BR112017006425A2
申请日:
2015.10.01
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
The present invention relates to a compound of formula (I) having an isoxazole structure which has excellent inhibitory activity against the mutant idh1 protein and inhibits the production of 2-hg by this protein, while the compound is also capable of inhibiting effectively the growth of various tumors expressing protein. in the formula, r1, r2, r3, y and z are as defined in claim 1.a presente invenção refere-se a um composto da formula geral (i) tendo uma estrutura de isoxazol que tem excelente atividade inibidora contra a proteína idh1 mutante e inibe a produção de 2-hg por esta proteína, enquanto o composto também é capaz de inibir efetivamente o crescimento de vários tumores que expressam a prote-ína. na fórmula, r1, r2, r3, y e z são conforme definidos na reivindi-cação 1.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充